Merck (MRK) Tops Q2 EPS by 12c; Raises Guidance

Merck (NYSE: MRK) reported Q2 EPS of ($2.06), $0.12 better than the analyst estimate of ($2.18). Revenue for the quarter came in at $15 billion versus the consensus estimate of $14.43 billion.

GUIDANCE:

Merck sees FY2023 EPS of $2.95-$3.05, versus the consensus of $2.60. Merck sees FY2023 revenue of $58.6-59.6 billion, versus the consensus of $53.2 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• TOYO Co., Ltd (TOYO) Misses Q2 EPS by 24c
• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance